Terms: = Uterine cancer AND HER1, YOR227W
10 results:
1. A pan-HER-targeted approach for recurrent or late-stage cervical cancer therapy: mechanisms, recent advances, and clinical prospects.
Liu Y; An Q; Zhao X
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4123-4131. PubMed ID: 32373948
[TBL] [Abstract] [Full Text] [Related]
2. Status of her1 and HER2 in peritoneal, ovarian and colorectal endometriosis and ovarian endometrioid adenocarcinoma.
Uzan C; Darai E; Valent A; Graesslin O; Cortez A; Rouzier R; Vielh P
Virchows Arch; 2009 May; 454(5):525-9. PubMed ID: 19294416
[TBL] [Abstract] [Full Text] [Related]
3. Measurement of mRNA of 11 biomarkers by RT-PCR to detect lymph node involvement in cervical cancer.
Samouelian V; Revillion F; Alloy N; Lhotellier V; Leblanc E; Peyrat JP
Int J Biol Markers; 2008; 23(2):74-82. PubMed ID: 18629779
[TBL] [Abstract] [Full Text] [Related]
4. The prognostic significance of human epidermal growth factor receptor correlations in squamous cell cervical carcinoma.
Fuchs I; Vorsteher N; Bühler H; Evers K; Sehouli J; Schaller G; Kümmel S
Anticancer Res; 2007; 27(2):959-63. PubMed ID: 17465227
[TBL] [Abstract] [Full Text] [Related]
5. Signaling interactions of rapamycin combined with erlotinib in cervical carcinoma xenografts.
Birle DC; Hedley DW
Mol Cancer Ther; 2006 Oct; 5(10):2494-502. PubMed ID: 17041093
[TBL] [Abstract] [Full Text] [Related]
6. [Molecular diagnostic and targeted therapy--"Barking dogs are going to bite": presentations from the 42nd Annual Meeting of the American Society of Clinical Oncology, Atlanta 2006].
Rody A; Loibl S; Kaufmann M
Zentralbl Gynakol; 2006 Oct; 128(5):233-41. PubMed ID: 17001557
[TBL] [Abstract] [Full Text] [Related]
7. Expression of the epidermal growth factor system in endometrioid endometrial cancer.
Ejskjaer K; Sørensen BS; Poulsen SS; Forman A; Nexø E; Mogensen O
Gynecol Oncol; 2007 Jan; 104(1):158-67. PubMed ID: 16962163
[TBL] [Abstract] [Full Text] [Related]
8. Correlation between human epidermal growth factor receptor family (EGFR, HER2, HER3, HER4), phosphorylated Akt (P-Akt), and clinical outcomes after radiation therapy in carcinoma of the cervix.
Lee CM; Shrieve DC; Zempolich KA; Lee RJ; Hammond E; Handrahan DL; Gaffney DK
Gynecol Oncol; 2005 Nov; 99(2):415-21. PubMed ID: 16157365
[TBL] [Abstract] [Full Text] [Related]
9. Endometrial stromal sarcomas frequently express epidermal growth factor receptor (EGFR, HER-1): potential basis for a new therapeutic approach.
Moinfar F; Gogg-Kamerer M; Sommersacher A; Regitnig P; Man YG; Zatloukal K; Denk H; Tavassoli FA
Am J Surg Pathol; 2005 Apr; 29(4):485-9. PubMed ID: 15767802
[TBL] [Abstract] [Full Text] [Related]
10. Comparative effects of heparin-binding epidermal growth factor-like growth factor on the growth of cultured human uterine leiomyoma cells and myometrial cells.
Wang J; Ohara N; Takekida S; Xu Q; Maruo T
Hum Reprod; 2005 Jun; 20(6):1456-65. PubMed ID: 15760954
[TBL] [Abstract] [Full Text] [Related]
